Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
31.7M
-
Shares change
-
-300K
-
Total reported value, excl. options
-
$143M
-
Value change
-
-$2.23M
-
Number of buys
-
24
-
Number of sells
-
-30
-
Price
-
$4.52
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2018
72 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q4 2018.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.7M shares
of 170M outstanding shares and own 18.61% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (12.7M shares), FMR LLC (6.13M shares), ARK Investment Management LLC (4.12M shares), BlackRock Inc. (2.26M shares), FEDERATED INVESTORS INC /PA/ (1.74M shares), Vanguard Group Inc (851K shares), RENAISSANCE TECHNOLOGIES LLC (805K shares), JPMORGAN CHASE & CO (399K shares), STATE STREET CORP (387K shares), and D. E. Shaw & Co., Inc. (308K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.